Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D King

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Pain|September 3, 2014
Conditioned pain modulation and offset analgesia: Different avenues to inhibit painChristopher D King
Pain|March 25, 2014
A possible mechanism underlying conditioned pain modulationChristopher D King
Pain|April 8, 2025
Exploring the interactions between circadian rhythms and sleep on pain: a call to actionCassandra Goldfarb, Christopher D King
Trends in Neurosciences|September 29, 2022
Disentangling the roles of circadian rhythms and sleep drive in experimental pain sensitivityHadas Nahman-Averbuch, Christopher D King
Journal of Psychopathology and Clinical Science|May 6, 2024
Assessing structural models of neighborhood and family sociodemographic characteristics and their relations with externalizing psychopathologyChristopher D King, Irwin D Waldman
Life Sciences|June 15, 2004
Inhibition of human hepatic CYP isoforms by mGluR5 antagonistsMitchell D Green, Xiaohui Jiang, Christopher D King
Molecular Pharmacology|October 16, 2004
Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4Jacqueline J Fremont, Regina W Wang, Christopher D King
Journal of Oral & Facial Pain and Headache|August 9, 2022
Fatigue in Adults with Chronic Arthralgia/Myalgia in the Temporomandibular Region: Associations with Poor Sleep Quality, Depression, Pain Intensity, and Future Pain InterferenceIan A Boggero, Hannah M Pickerill, Christopher D King
Sleep Medicine|August 29, 2020
Experimental sleep restriction increases somatic complaints in healthy adolescentsKendra N Krietsch, Christopher D King, Dean W Beebe
Neuroscience Letters|September 13, 2005
In vitro metabolic studies on the selective metabotropic glutamate receptor sub-type 5 (mGluR5) antagonist 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]-pyridine (MTEP)Mitchell D Green, Xiaoqing Yang, Merryl Cramer, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Pain|September 3, 2014
Conditioned pain modulation and offset analgesia: Different avenues to inhibit painChristopher D King
Pain|March 25, 2014
A possible mechanism underlying conditioned pain modulationChristopher D King
Pain|April 8, 2025
Exploring the interactions between circadian rhythms and sleep on pain: a call to actionCassandra Goldfarb, Christopher D King
Trends in Neurosciences|September 29, 2022
Disentangling the roles of circadian rhythms and sleep drive in experimental pain sensitivityHadas Nahman-Averbuch, Christopher D King
Journal of Psychopathology and Clinical Science|May 6, 2024
Assessing structural models of neighborhood and family sociodemographic characteristics and their relations with externalizing psychopathologyChristopher D King, Irwin D Waldman
Life Sciences|June 15, 2004
Inhibition of human hepatic CYP isoforms by mGluR5 antagonistsMitchell D Green, Xiaohui Jiang, Christopher D King
Molecular Pharmacology|October 16, 2004
Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4Jacqueline J Fremont, Regina W Wang, Christopher D King
Journal of Oral & Facial Pain and Headache|August 9, 2022
Fatigue in Adults with Chronic Arthralgia/Myalgia in the Temporomandibular Region: Associations with Poor Sleep Quality, Depression, Pain Intensity, and Future Pain InterferenceIan A Boggero, Hannah M Pickerill, Christopher D King
Sleep Medicine|August 29, 2020
Experimental sleep restriction increases somatic complaints in healthy adolescentsKendra N Krietsch, Christopher D King, Dean W Beebe
Neuroscience Letters|September 13, 2005
In vitro metabolic studies on the selective metabotropic glutamate receptor sub-type 5 (mGluR5) antagonist 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]-pyridine (MTEP)Mitchell D Green, Xiaoqing Yang, Merryl Cramer, et al.
Pageof 11